WO2002016944A3 - Synthetic nucleic acid molecule compositions and methods of preparation - Google Patents

Synthetic nucleic acid molecule compositions and methods of preparation Download PDF

Info

Publication number
WO2002016944A3
WO2002016944A3 PCT/US2001/026566 US0126566W WO0216944A3 WO 2002016944 A3 WO2002016944 A3 WO 2002016944A3 US 0126566 W US0126566 W US 0126566W WO 0216944 A3 WO0216944 A3 WO 0216944A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
synthetic nucleic
preparation
methods
acid molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/026566
Other languages
French (fr)
Other versions
WO2002016944A2 (en
Inventor
Keith V Wood
Monika G Wood
Yao Zhuang
Aileen Paguio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Promega Corp
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AU2001285278A priority Critical patent/AU2001285278B2/en
Priority to DE60140898T priority patent/DE60140898D1/en
Priority to AT01964425T priority patent/ATE452905T1/en
Priority to JP2002521985A priority patent/JP2004520807A/en
Priority to CA002420328A priority patent/CA2420328A1/en
Priority to DK01964425.1T priority patent/DK1341808T3/en
Application filed by Promega Corp filed Critical Promega Corp
Priority to EP01964425A priority patent/EP1341808B1/en
Priority to AU8527801A priority patent/AU8527801A/en
Publication of WO2002016944A2 publication Critical patent/WO2002016944A2/en
Anticipated expiration legal-status Critical
Publication of WO2002016944A3 publication Critical patent/WO2002016944A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

A method to prepare synthetic nucleic acid molecules having reduced inappropriate or unintended transcriptional characteristics when expressed in a particular host cell.
PCT/US2001/026566 2000-08-24 2001-08-24 Synthetic nucleic acid molecule compositions and methods of preparation Ceased WO2002016944A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
DE60140898T DE60140898D1 (en) 2000-08-24 2001-08-24 SYNTHETIC NUCLEIC ACID MOLECULE COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
AT01964425T ATE452905T1 (en) 2000-08-24 2001-08-24 SYNTHETIC NUCLEIC ACID MOLECULE COMPOSITIONS AND METHODS FOR THEIR PRODUCTION
JP2002521985A JP2004520807A (en) 2000-08-24 2001-08-24 Synthetic nucleic acid molecule composition and preparation method
CA002420328A CA2420328A1 (en) 2000-08-24 2001-08-24 Synthetic nucleic acid molecule compositions and methods of preparation
DK01964425.1T DK1341808T3 (en) 2000-08-24 2001-08-24 Synthetic nucleic acid molecule compositions and methods of preparation
AU2001285278A AU2001285278B2 (en) 2000-08-24 2001-08-24 Synthetic nucleic acid molecule compositions and methods of preparation
EP01964425A EP1341808B1 (en) 2000-08-24 2001-08-24 Synthetic nucleic acid molecule compositions and methods of preparation
AU8527801A AU8527801A (en) 2000-08-24 2001-08-24 Synthetic nucleic acid molecule compositions and methods of preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/645,706 US7879540B1 (en) 2000-08-24 2000-08-24 Synthetic nucleic acid molecule compositions and methods of preparation
US09/645,706 2000-08-24

Publications (2)

Publication Number Publication Date
WO2002016944A2 WO2002016944A2 (en) 2002-02-28
WO2002016944A3 true WO2002016944A3 (en) 2003-06-26

Family

ID=24590123

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/026566 Ceased WO2002016944A2 (en) 2000-08-24 2001-08-24 Synthetic nucleic acid molecule compositions and methods of preparation

Country Status (10)

Country Link
US (3) US7879540B1 (en)
EP (1) EP1341808B1 (en)
JP (3) JP2004520807A (en)
AT (1) ATE452905T1 (en)
AU (2) AU2001285278B2 (en)
CA (1) CA2420328A1 (en)
DE (1) DE60140898D1 (en)
DK (1) DK1341808T3 (en)
ES (1) ES2335268T3 (en)
WO (1) WO2002016944A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9487520B2 (en) 2010-11-02 2016-11-08 Promega Corporation Coelenterazine derivatives and methods of using same

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602677B1 (en) * 1997-09-19 2003-08-05 Promega Corporation Thermostable luciferases and methods of production
US7879540B1 (en) 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
US20030157643A1 (en) * 2000-08-24 2003-08-21 Almond Brian D Synthetic nucleic acids from aquatic species
US7413874B2 (en) 2002-12-09 2008-08-19 University Of Miami Nucleic acid encoding fluorescent proteins from aquatic species
CN1784496B (en) * 2003-05-06 2010-08-25 独立行政法人产业技术综合研究所 Multi-gene transcription activity assay system
US20070077563A1 (en) * 2003-08-29 2007-04-05 Takara Bio Inc. Method of searching for functional nucleotide molecule
EP2308978B8 (en) 2003-10-10 2015-04-08 Promega Corporation Luciferase biosensor
WO2006046132A2 (en) * 2004-09-17 2006-05-04 Institut Pasteur Method for modulating the evolution of a polypeptide encoded by a nucleic acid sequence
US7728118B2 (en) 2004-09-17 2010-06-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
WO2007030473A2 (en) * 2005-09-06 2007-03-15 Stanford University Luciferases and methods for making and using the same
WO2007058140A1 (en) 2005-11-16 2007-05-24 Toyo Boseki Kabushiki Kaisha Luciferase gene optimized for use in imaging of intracellular luminescence
EP2004813B1 (en) 2006-04-03 2015-06-03 Promega Corporation Permuted and nonpermuted luciferase biosensors binding cyclic nucleotides
WO2007139584A2 (en) * 2006-05-25 2007-12-06 Institute For Advanced Study Methods for identifying sequence motifs, and applications thereof
AU2007345319B2 (en) 2006-07-13 2012-09-06 Institute For Advanced Study Viral inhibitory nucleotide sequences and vaccines
EP2374875B1 (en) 2006-10-30 2015-09-02 Promega Corporation Mutant hydrolase proteins with enhanced kinetics and funcitional expression
LT2167540T (en) 2007-06-29 2018-04-25 F. Hoffmann-La Roche Ag Heavy chain mutant leading to improved immunoglobulin production
JP5258084B2 (en) * 2008-01-07 2013-08-07 株式会社ＰｒｏｂｅＸ Method for detecting protein-protein interaction
EP2281046B1 (en) 2008-05-19 2012-01-25 Promega Corporation LUCIFERASE BIOSENSORS FOR cAMP
JP4849698B2 (en) 2009-05-29 2012-01-11 国立大学法人 東京大学 Sensitive detection method for protein-protein interaction
EP3508570B1 (en) 2010-05-11 2020-07-22 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
US9290794B2 (en) 2010-05-11 2016-03-22 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
EP2580329B1 (en) * 2010-06-10 2018-07-11 Active Motif, Inc. Modified renilla luciferase nucleic acids and methods of use
SG10202103336SA (en) 2010-11-02 2021-04-29 Promega Corp Novel coelenterazine substrates and methods of use
HUE046506T2 (en) 2011-06-16 2020-03-30 Univ California Synthetic gene clusters
EP2776573A1 (en) 2011-11-11 2014-09-17 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
EP3597741A1 (en) 2012-04-27 2020-01-22 Duke University Genetic correction of mutated genes
WO2014071182A1 (en) 2012-11-01 2014-05-08 Massachusetts Institute Of Technology Directed evolution of synthetic gene cluster
JP6604938B2 (en) 2013-03-15 2019-11-13 プロメガ コーポレイション Substrates for covalently anchoring proteins to functional groups or solid surfaces
US9828582B2 (en) 2013-03-19 2017-11-28 Duke University Compositions and methods for the induction and tuning of gene expression
US9790537B2 (en) 2014-01-29 2017-10-17 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
EP3099691B1 (en) 2014-01-29 2019-11-20 Promega Corporation Pro-substrates for live cell applications
US9732373B2 (en) * 2014-09-11 2017-08-15 Promega Corporation Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence
US10676726B2 (en) 2015-02-09 2020-06-09 Duke University Compositions and methods for epigenome editing
CN108602729B (en) 2015-07-13 2022-07-05 皮沃特生物公司 Methods and compositions for improving plant traits
WO2017062412A1 (en) 2015-10-05 2017-04-13 Massachusetts Institute Of Technology Nitrogen fixation using refactored nif clusters
EP4089175A1 (en) 2015-10-13 2022-11-16 Duke University Genome engineering with type i crispr systems in eukaryotic cells
EA201891317A3 (en) 2015-11-30 2019-04-30 Дьюк Юниверсити THERAPEUTIC TARGETS FOR CORRECTION OF HUMAN DISTROPHIN GENE BY EDITING GENES AND METHODS OF THEIR APPLICATION
US20190127713A1 (en) 2016-04-13 2019-05-02 Duke University Crispr/cas9-based repressors for silencing gene targets in vivo and methods of use
WO2018017754A1 (en) 2016-07-19 2018-01-25 Duke University Therapeutic applications of cpf1-based genome editing
WO2018049241A1 (en) 2016-09-09 2018-03-15 Promega Corporation Dual protected pro-coelenterazine substrates
JP7234116B2 (en) 2017-01-12 2023-03-07 ピボット バイオ， インコーポレイテッド Methods and compositions for improving plant traits
JP2021500907A (en) 2017-10-25 2021-01-14 ピボット バイオ， インコーポレイテッド Gene target for nitrogen fixation for the purpose of improving plant traits
AU2018354221B2 (en) 2017-10-25 2025-04-17 Pivot Bio, Inc. Methods and compositions for improving engineered microbes that fix nitrogen
CA3022981C (en) 2017-11-01 2025-05-06 Queen's University At Kingston Hippo pathway bioluminescent biosensor
WO2019144061A1 (en) 2018-01-19 2019-07-25 Duke University Genome engineering with crispr-cas systems in eukaryotes
CN112739668A (en) 2018-06-27 2021-04-30 皮沃特生物股份有限公司 Agricultural compositions comprising reconstituted nitrogen-fixing microorganisms
KR20210060434A (en) 2018-07-11 2021-05-26 피벗 바이오, 인크. Temporal and spatial targeting dynamic nitrogen delivery by remodeled microorganisms
WO2020146372A1 (en) 2019-01-07 2020-07-16 Pivot Bio, Inc. Plant colonization assays using natural microbial barcodes
WO2020185312A2 (en) 2019-01-25 2020-09-17 President And Fellows Of Harvard College Compositions and method for synthesizing nucleic acids
WO2020190363A1 (en) 2019-03-19 2020-09-24 Massachusetts Institute Of Technology Control of nitrogen fixation in rhizobia that associate with cereals
EP3990484A1 (en) 2019-06-28 2022-05-04 F. Hoffmann-La Roche AG Method for the production of an antibody
CN115176027A (en) 2019-12-12 2022-10-11 哈佛大学校长及研究员协会 Compositions and methods for light-directed biomolecular barcoding
US20230203567A1 (en) 2020-04-22 2023-06-29 President And Fellows Of Harvard College Isothermal methods, compositions, kits, and systems for detecting nucleic acids
PY2134250A (en) 2020-05-01 2022-01-28 Pivot Bio Inc STABLE LIQUID FORMULATIONS FOR NITROGEN-FIXING MICROORGANISMS
AU2020445067A1 (en) 2020-05-01 2022-12-01 Pivot Bio, Inc. Measurement of nitrogen fixation and incorporation
JP2023545038A (en) 2020-10-06 2023-10-26 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Methods, compositions, kits, and systems for signal-on detection of neutralizing targets
EP4519290A1 (en) 2022-05-04 2025-03-12 Promega Corporation Circularly permuted dehalogenase variants
WO2023215505A1 (en) 2022-05-04 2023-11-09 Promega Corporation Modified dehalogenase with extended surface loop regions
WO2023215452A2 (en) 2022-05-04 2023-11-09 Promega Corporation Split modified dehalogenase variants
IL317874A (en) 2022-06-24 2025-02-01 Tune Therapeutics Inc Compositions, systems, and methods for reducing low-density lipoprotein through targeted gene repression
EP4729632A1 (en) 2024-10-18 2026-04-22 AskBio Inc. Method of synthesizing dna

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018853A1 (en) * 1994-01-03 1995-07-13 Promega Corporation Mutant luciferases
US5670356A (en) * 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
WO1999014336A2 (en) * 1997-09-19 1999-03-25 Promega Corporation Thermostable luciferases and methods of production

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE428379B (en) 1978-05-31 1983-06-27 Lkb Produkter Ab DETERMINATION OF ATOL AND REAGENTS OF BIOLUMINISM
US4412001A (en) 1981-01-30 1983-10-25 Board Of Trustees Of The University Of Illinois Isolation of bacterial luciferase
US4503142A (en) 1982-06-25 1985-03-05 Litton Bionetics, Inc. Open reading frame vectors
US4581335A (en) 1982-12-01 1986-04-08 Texas A&M University System Process for producing a cloned luciferase-synthesizing microorganism
US5096825A (en) 1983-01-12 1992-03-17 Chiron Corporation Gene for human epidermal growth factor and synthesis and expression thereof
US5380831A (en) 1986-04-04 1995-01-10 Mycogen Plant Science, Inc. Synthetic insecticidal crystal protein gene
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US5583024A (en) 1985-12-02 1996-12-10 The Regents Of The University Of California Recombinant expression of Coleoptera luciferase
US5221623A (en) 1986-07-22 1993-06-22 Boyce Thompson Institute For Plant Research, Inc. Use of bacterial luciferase structural genes for cloning and monitoring gene expression in microorganisms and for tagging and identification of genetically engineered organisms
US4968613A (en) 1987-07-29 1990-11-06 Kikkoman Corporation Luciferase gene and novel recombinant DNA as well as a method of producing luciferase
US5182202A (en) 1987-11-30 1993-01-26 Kikkoman Corporation Purified luciferase from luciola cruciata
JPH088864B2 (en) 1988-04-12 1996-01-31 キッコーマン株式会社 Luciferase
DE68910036T2 (en) 1988-07-01 1994-03-31 Kikkoman Corp Luciferase gene and new recombinant DNA as well as processes for the production of luciferase.
DE68927437T2 (en) 1988-08-09 1997-03-06 Toray Industries METHOD FOR PRODUCING LUCIFERASE BY RECOMBINANT EXPRESSION OF A LUCIFERASE-ENCODING GENE
US5604123A (en) 1988-08-09 1997-02-18 Toray Industries, Inc. Luciferase, gene encoding the same and production process of the same
JPH0771485B2 (en) 1988-09-01 1995-08-02 キッコーマン株式会社 Luciferase production method
US5196524A (en) 1989-01-06 1993-03-23 Eli Lilly And Company Fusion reporter gene for bacterial luciferase
CA2009925C (en) 1989-02-14 2002-10-01 Koichi Kondo Method for enhancement of chemiluminescence
FI901681A7 (en) 1989-04-10 1990-10-11 Ela Tech Inc Method for increasing the sensitivity of luminescence analyses
JPH03167288A (en) 1989-11-27 1991-07-19 Chisso Corp Method for sensitized luminescence of aequorin by surface active agent
US5292658A (en) 1989-12-29 1994-03-08 University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center Cloning and expressions of Renilla luciferase
US5219737A (en) 1990-03-27 1993-06-15 Kikkoman Corporation Mutant luciferase of a firefly, mutant luciferase genes, recombinant dnas containing the genes and a method of producing mutant luciferase
JPH05506578A (en) 1990-04-18 1993-09-30 プラント・ジエネテイツク・システムズ・エヌ・ベー Modified BACILLUS THURINGIENSIS insecticidal crystal protein genes and their expression in plant cells
US5283179A (en) 1990-09-10 1994-02-01 Promega Corporation Luciferase assay method
DK0575319T3 (en) 1991-03-11 2000-07-10 Univ Georgia Res Found Cloning and expression of Renilla luciferase
US5229285A (en) 1991-06-27 1993-07-20 Kikkoman Corporation Thermostable luciferase of firefly, thermostable luciferase gene of firefly, novel recombinant dna, and process for the preparation of thermostable luciferase of firefly
CA2122261A1 (en) * 1991-10-30 1993-05-13 Marc Cornelissen Modified genes and their expression in plant cells
US5629168A (en) 1992-02-10 1997-05-13 British Technology Group Limited Chemiluminescent enhancers
AT401526B (en) 1993-02-10 1996-09-25 Scheirer Winfried REAGENT SOLUTION TO STABILIZE LUMINESCENCE IN LUCIFERASE MEASUREMENT
CA2104815A1 (en) 1993-02-26 1994-08-27 Naotaka Kuroda Method for measuring adenyl group-containing substances
US5610335A (en) 1993-05-26 1997-03-11 Cornell Research Foundation Microelectromechanical lateral accelerometer
US6118047A (en) 1993-08-25 2000-09-12 Dekalb Genetic Corporation Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction
JPH0767696A (en) 1993-09-06 1995-03-14 Tosoh Corp Background emission reduction method
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
GB9501170D0 (en) 1994-03-23 1995-03-08 Secr Defence Luciferases
US5795737A (en) 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US5786464C1 (en) 1994-09-19 2012-04-24 Gen Hospital Corp Overexpression of mammalian and viral proteins
WO1996022376A1 (en) 1995-01-20 1996-07-25 The Secretary Of State For Defence Mutant luciferases
US5744320A (en) 1995-06-07 1998-04-28 Promega Corporation Quenching reagents and assays for enzyme-mediated luminescence
AU725609C (en) 1995-08-18 2002-01-03 Morphosys Ag Protein/(poly)peptide libraries
US6020192A (en) 1996-01-18 2000-02-01 University Of Florida Humanized green fluorescent protein genes and methods
US5874304A (en) 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
JPH09294600A (en) 1996-04-26 1997-11-18 Kikkoman Corp Determination of activity of a plurality of promoters
AU717542B2 (en) * 1996-06-11 2000-03-30 Merck & Co., Inc. Synthetic hepatitis C genes
JPH1087621A (en) 1996-09-13 1998-04-07 Sankyo Co Ltd Enhancer for lucigenin chemiluminescence
US6114148C1 (en) 1996-09-20 2012-05-01 Gen Hospital Corp High level expression of proteins
JP2001504325A (en) 1996-09-27 2001-04-03 マキシジェン，インコーポレイテッド A method for optimization of gene therapy by recursive sequence shuffling and selection
US5976796A (en) 1996-10-04 1999-11-02 Loma Linda University Construction and expression of renilla luciferase and green fluorescent protein fusion genes
JP3167288B2 (en) 1997-03-17 2001-05-21 株式会社バンダイ Portable electronic equipment
GB9707486D0 (en) 1997-04-11 1997-05-28 Secr Defence Enzyme assays
US6074859A (en) 1997-07-08 2000-06-13 Kikkoman Corporation Mutant-type bioluminescent protein, and process for producing the mutant-type bioluminescent protein
WO1999004024A2 (en) * 1997-07-15 1999-01-28 Dow Agrosciences Llc Nucleotide sequences of genes encoding sink proteins and uses thereof for improving the nutritional quality of feeds
US6602677B1 (en) 1997-09-19 2003-08-05 Promega Corporation Thermostable luciferases and methods of production
US6306600B1 (en) 1998-04-17 2001-10-23 Clontech Laboratories, Inc. Rapidly degrading GFP-fusion proteins and methods of use
US6130313A (en) 1997-10-02 2000-10-10 Clontech Laboratories, Inc. Rapidly degrading GFP-fusion proteins
US7090976B2 (en) 1999-11-10 2006-08-15 Rigel Pharmaceuticals, Inc. Methods and compositions comprising Renilla GFP
US6700038B1 (en) 1999-03-31 2004-03-02 Wisconsin Alumni Research Foundation Plant expression vectors based on the flock house virus genome
CA2385162A1 (en) 1999-09-30 2001-04-05 William L. Fodor Compositions and methods for altering gene expression
CA2383642C (en) 1999-10-14 2014-03-25 Clontech Laboratories, Inc. Anthozoa derived chromophores/fluorophores and methods for using the same
FR2812883B1 (en) 2000-08-11 2002-10-18 Aventis Cropscience Sa USE OF HPPD INHIBITORS AS SELECTING AGENTS IN PLANT TRANSFORMATION
US7879540B1 (en) 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
US20030157643A1 (en) 2000-08-24 2003-08-21 Almond Brian D Synthetic nucleic acids from aquatic species
WO2002094992A2 (en) 2001-05-18 2002-11-28 Rigel Pharmaceuticals, Incorporated Directed evolution of protein in mammalian cells
EP1444245A4 (en) 2001-11-13 2005-11-16 Clontech Lab Inc NOVEL CHROMOPHORES / FLUOROPHORES AND METHODS OF USE
JP4528623B2 (en) 2002-09-16 2010-08-18 プロメガ コーポレイション Rapidly degradable reporter fusion protein
WO2004042010A2 (en) 2002-10-30 2004-05-21 University Of Tennessee Research Foundation Modified luciferase nucleic acids and methods of use
JP4311003B2 (en) 2002-12-02 2009-08-12 アイシン精機株式会社 Prokaryotic gene expression analysis method
US6878531B1 (en) 2003-11-10 2005-04-12 Medical College Of Georgia Research Institute Method for multiple site-directed mutagenesis
US7728118B2 (en) 2004-09-17 2010-06-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018853A1 (en) * 1994-01-03 1995-07-13 Promega Corporation Mutant luciferases
US5670356A (en) * 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
WO1999014336A2 (en) * 1997-09-19 1999-03-25 Promega Corporation Thermostable luciferases and methods of production

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EBI [online] 8 August 2000 (2000-08-08), FERBITZ L. ET AL.: "A synthetic gene coding for Renilla luciferase is a versatile expression marker in green algae", XP002230923, Database accession no. AY004213 *
KIM C.H. ET AL.: "Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells", GENE, vol. 199, no. 1-2, 15 October 1997 (1997-10-15), pages 293 - 301, XP004126394, ISSN: 0378-1119 *
PAN W. ET AL.: "Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells", NUCLEIC ACIDS RESEARCH, vol. 27, no. 4, 15 February 1999 (1999-02-15), pages 1094 - 1103, XP000953100, ISSN: 0305-1048 *
WOOD K.V.: "The chemical mechanism and evolutionary development of beetle bioluminescence", PHOTOCHEMISTRY AND PHOTOBIOLOGY, vol. 62, no. 4, 1995, pages 662 - 673, XP000983576, ISSN: 0031-8655 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9487520B2 (en) 2010-11-02 2016-11-08 Promega Corporation Coelenterazine derivatives and methods of using same

Also Published As

Publication number Publication date
ATE452905T1 (en) 2010-01-15
US7906282B2 (en) 2011-03-15
DE60140898D1 (en) 2010-02-04
DK1341808T3 (en) 2010-04-12
US20080090291A1 (en) 2008-04-17
AU2001285278B2 (en) 2008-05-08
CA2420328A1 (en) 2002-02-28
ES2335268T3 (en) 2010-03-24
JP2007006910A (en) 2007-01-18
EP1341808A2 (en) 2003-09-10
JP2010081942A (en) 2010-04-15
WO2002016944A2 (en) 2002-02-28
US7879540B1 (en) 2011-02-01
JP2004520807A (en) 2004-07-15
EP1341808B1 (en) 2009-12-23
AU8527801A (en) 2002-03-04
US20060127988A1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
WO2002016944A3 (en) Synthetic nucleic acid molecule compositions and methods of preparation
WO2006034061A3 (en) Synthetic nucleic acid molecule and methods of preparation
AU2001273453A1 (en) Nucleic acid hairpin probes and uses thereof
AU2001259846A1 (en) Methods and compositions for enhancing the delivery of a nucleic acid to a cell
AU2002346662A1 (en) Methods and compositions for selectively cleaving dna containing duplex acids in a complex nucleic acid mixture
AU2003228649A1 (en) Compositions and methods related to two-arm nucleic acid probes
WO2003060144A3 (en) High fidelity dna polymerase compositions and uses therefor
AU2003228627A1 (en) Application of cantilevers in nucleic acid sequencing
WO2002050289A8 (en) Methods for the production of multimeric proteins, and related compositions
AU8909998A (en) Methods and compositions for cloning nucleic acid molecules
WO2002004488A3 (en) Nucleic acid binding polypeptides
AU2002249787A1 (en) Compositions and methods relating to lung specific genes and proteins
AU2001293583A1 (en) Antisense iap nucleic acids and uses thereof
WO2001055342A3 (en) Synthetic genes for enhanced expression
AU1941601A (en) Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
AU2002220009A1 (en) Compositions and methods relating to lung specific genes and proteins
AU2001246662A1 (en) Rare earth sulphide composition with improved chemical stability, preparation method and use thereof as pigment
AU2001268232A1 (en) Compositions, methods, and kits relating to resistin-like molecules
AU2001272932A1 (en) Angiostatin and endostatin binding proteins and methods of use
AU8505898A (en) Nucleic acid compositions and methods of introducing nucleic acids into cells
AU2002239739A1 (en) Compositions, methods and kits relating to remodelin
AU2001263836A1 (en) Method of nucleic acid recovery
AU2002228711A1 (en) Hydroxy-alkanoic acid ester monomer compositions and methods of making same
AU2002217991A1 (en) Compositions and methods relating to prostate specific genes and proteins
AU2002364968A1 (en) Compositions and methods relating to hepatic specific genes and proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002521985

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2420328

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001285278

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2001964425

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001964425

Country of ref document: EP